- $8.76bn
- $10.88bn
- $6.84bn
- 78
- 62
- 88
- 90
Annual income statement for Icl, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,043 | 6,955 | 10,015 | 7,536 | 6,841 |
| Cost of Revenue | |||||
| Gross Profit | 1,490 | 2,611 | 5,032 | 2,671 | 2,256 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,841 | 5,745 | 6,499 | 6,395 | 6,066 |
| Operating Profit | 202 | 1,210 | 3,516 | 1,141 | 775 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 49 | 1,092 | 3,404 | 974 | 636 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 24 | 832 | 2,219 | 687 | 464 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 11 | 783 | 2,159 | 647 | 407 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 11 | 783 | 2,159 | 647 | 407 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.043 | 0.602 | 1.68 | 0.501 | 0.317 |
| Dividends per Share |